Literature DB >> 10052851

Effect of butylidenephthalide on calcium mobilization in isolated rat aorta.

W C Ko1, C Y Charng, J R Sheu, S H Tzeng, C M Chen.   

Abstract

Butylidenephthalide (Bdph), an antispasmodic compound originally isolated from the rhizome of Ligusticum chuaxiong, has a selective anti-anginal effect without changing blood pressure. Experiments have been performed to determine the mechanism of this action. Synthetic Z-butylidenephthalide concentration-dependently relaxed phenylephrine (1 microM)- or KCl (60 mM)-induced precontractions of intact and denuded rat aorta rings. The relaxation induced by Bdph was endothelium-independent. Bdph (30-300 microM) concentration-dependently reduced cumulative phenylephrine- and KCl-induced contractions of intact rat aortic rings and non-competitively inhibited their log concentration-response curves. The pD2' values of Bdph for phenylephrine- and KCl-induced contraction were 3.66+/-0.13 (n = 8) and 3.71+/-0.07 (n = 8), respectively, which were not significantly different from each other. Bdph also concentration-dependently reduced cumulative Ca2+-induced contractions of intact rat aortic rings in high-KCl (60 mM) Ca2+-free physiological salt solution and non-competitively inhibited its log concentration-response curve. The pD2' value of Bdph for the Ca2+-induced contractions was 3.21+/-0.01 (n = 7) which was significantly different from the pD2' value obtained from the cumulative KCl-induced contractions. These results suggest that Bdph inhibits calcium release from calcium stores more selectively than calcium influx from extracellular space via voltage-dependent calcium channels. The inhibition by Bdph of calcium release from KCl-sensitive calcium stores might be similar to its inhibition of calcium release from phenylephrine-sensitive calcium stores. However, because phenylephrine generates inositol-1,4,5-trisphosphate (IP3) whereas KCl does not, the inhibitory effect of Bdph might not be related to IP3 production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10052851     DOI: 10.1111/j.2042-7158.1998.tb03361.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Butylidenephthalide antagonizes cromakalim-induced systolic pressure reduction in conscious normotensive rats.

Authors:  Chung-Hung Shih; Yu-Jing Lin; Chi-Ming Chen; Wun-Chang Ko
Journal:  BMC Complement Altern Med       Date:  2015-10-05       Impact factor: 3.659

2.  n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.

Authors:  Ru-Huei Fu; Horng-Jyh Harn; Shih-Ping Liu; Chang-Shi Chen; Wen-Lin Chang; Yue-Mi Chen; Jing-En Huang; Rong-Jhu Li; Sung-Yu Tsai; Huey-Shan Hung; Woei-Cherng Shyu; Shinn-Zong Lin; Yu-Chi Wang
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

3.  Butylidenephthalide blocks potassium channels and enhances basal tension in isolated guinea-pig trachea.

Authors:  Hsin-Te Hsu; You-Lan Yang; Wan-Chen Chen; Chi-Ming Chen; Wun-Chang Ko
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

4.  Mechanisms of butylidenephthalide for twitch facilitation in electrically stimulated mouse vas deferens.

Authors:  Chung-Hung Shih; Chi-Ming Chen; Wun-Chang Ko
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.